Catalog Number SCF10X25AGEN |
Device Problems
Patient-Device Incompatibility (2682); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Abdominal Pain (1685); Capsular Contracture (1761); Erythema (1840); Fever (1858); Inflammation (1932); Local Reaction (2035); Seroma (2069)
|
Event Date 12/10/2014 |
Event Type
Injury
|
Event Description
|
Healthcare professional reported implantation of seri and concomitant non-allergan breast implant and non-allergan alloderm brand surgical scaffold on (b)(6) 2014 for tissue support during right side breast reconstruction surgery.Post-implantation, on (b)(6) 2014, patient presented with redness and "little red bumps".Treatment included keflex, cipro, bactrim, and intravenous vancomycin.The device remains implanted and is unavailable for return.
|
|
Manufacturer Narrative
|
Further information regarding event and product details has been requested.No additional information is available at this time.The events of "redness" and "little red bumps" are physiological complications, and analysis of the device generally does not assist allergan in determining the probable cause of these events.These events are being reported because medical intervention was required, although device-relatedness has not been established.
|
|
Event Description
|
Healthcare professional reported additionally that the patient developed a fever immediately post-implantation.The device was removed and discarded on (b)(6) 2015.Upon removal, the healthcare professional noted a seroma in the breast pocket.The healthcare professional concluded that the device had been physiologically rejected.
|
|
Manufacturer Narrative
|
The patient term codes for fever and seroma are submitted in addition to the previously reported patient codes, not in replacement.The physician discarded the device when it was explanted, and it is no longer available for return.Therefore, allergan will not receive the device and no analysis or testing will be done.These events are being reported because medical intervention was required, although device-relatedness has not been established.
|
|
Manufacturer Narrative
|
The patient term code for inflammation is submitted in addition to the previously reported patient codes, not in replacement.These events are being reported because medical intervention was required, although device-relatedness has not been established.
|
|
Event Description
|
Healthcare professional reported additional information indicating the patient requires additional surgery to correct capsular contracture associated with her new breast implants, and residual inflammation that has been attributed to the seri device by the physician.
|
|
Manufacturer Narrative
|
The events of pain and capsular contracture are physiological complications, and analysis of the device generally does not assist allergan in determining a probable cause for these events.
|
|
Event Description
|
Patient reported that seri surgical scaffold was placed bilaterally ¿under the base of each implant and base of [patient] chest wall¿ on (b)(6) 2014.After ¿a couple weeks,¿ the patient experienced ¿low-grade fevers¿ and ¿blotchy redness on the skin of [patient] right breast.¿ over the following two months, patient noted continuation of ¿low-grade fevers¿ as well as ¿marked changes in the appearance of both [patient] breasts¿ and ¿pain¿.Mammography showed ¿fluid buildup along the inferior aspect of both breast implants.¿ on (b)(6) 2015, the patient underwent bilateral explant of both breast implants and the concomitantly placed seri surgical scaffold.Explant was attributed to ¿severe inflammatory response¿ and ¿failure of the seri surgical scaffold resulting in bilateral capsular contracture.¿.
|
|
Search Alerts/Recalls
|